HIGHLIGHTS
- who: Maaike Biewenga from the Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands have published the Article: Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis, in the Journal: (JOURNAL)
- future: More research on the value of IgG and other markers that reflect immunological activity during treatment is needed.
SUMMARY
Findings Higher AST during treatment was independently from age, AST at diagnosis and liver cirrhosis associated with worse survival. IgG at 6 or 12 months was not associated with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.